ClinicalTrials.gg
CompletedNCT05872061SenegalMPSUpdated Jun 1, 2023

Senegal Market Study for Food-to-Food Fortified (F2F) Instant Porridge Flours

An observational study in Iron-deficiency and Vitamin A Deficiency, sponsored by Purdue University. Completed at 1 site in Senegal. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-06-01.

Sponsored by Purdue University · Observational

Study type
Observational
Model
Cohort
Time perspective
Cross-sectional
Enrollment
1,800
Ages
18 Years and older
Sex
All
01

Study summary

The overall hypotheses is that a product designed with optimized nutritional characteristics, based on consumer preferences and leveraging local nutrient dense ingredients, can successfully deliver nutrition through sustainable market-driven approaches.

The objectives of this study were 1) to assess the nutritional adequacy of urban Senegalese households with children and 2) to determine the market potential of a locally sourced and manufactured, blended fortified, cereal-based product for the improvement of micronutrient deficiencies among children aged 24-60 months. This study simulates a market study, the investigators will conduct a product launch, determine market potential based on sales, evaluate marketing strategy to increase market share, and model the nutritional contribution of FtFF/traditionally fortified product for iron, zinc, and vitamin A. The investigators expect to provide a thorough evaluation of a business-driven strategy (for profit, social enterprise) as a sustainable tool to decrease micronutrient deficiencies.

Read the detailed description

Basic design:

Participants will be approached/recruited by research assistants on the ground at designated local markets. Potential participants will be approached and consented if they agree to join the study at the time of recruitment. Research assistants will read the consent form to the participants and ensure they understand it.

Products will be produced, distributed on a weekly basis to sites. The investigators plan on introducing the "new" product to consumers at random at in-store displays at individual locations for 2 weeks, and then continue to promote (advertise) and sell the placed product for a period of 8 weeks. The following schedules are proposed:

Weeks 1-2: Product demonstrations and sampling for consumers (with promotion and free samples) Weeks 3-5: Product sold at below market cost of other millet or cereal flour products (as part of active promotion) Weeks 6-10: At one half of the locations, product sold at parity to millet or other cereal products (with advertising but no additional promotion, i.e. discount) Weeks 6-10: At one half of the locations product sold at parity +20% price to millet or other cereal products (with advertising but no additional promotion)

Data to be collected both from store managers and individual consumers. Enumerators will be trained and placed at each sales' location in the morning and evening to coincide with peak shopping times. They will be tasked with collecting a random sample of consumers who are purchasing cereals (1,200 total over 10 weeks). In this sample, both purchasers and non-purchasers of the FtFF fortified products will be identified and consented. Phone numbers will be collected and a follow up appointment/interview scheduled with half of them (600). Enumerators will also coordinate the collection of data from point of sale managers:

  1. Total volume/units of FtFF fortified product sold
  2. Total volume/units millet products sold
  3. Total value of FtFF fortified product sold
  4. TotaI value of millet product sold
  5. Product comments from consumers (include any returns or complaints)
  6. Number of repeat purchasers

Follow up interviews with consumers will be conducted at a private location close to the centralized market sites or points of original purchase within 2 weeks. This is to enable follow up without inconveniencing participant.

Product Production and Distribution Plan: Through a local commercial food processor Product form: 500 g size for sale. 50 g size for promotion.

02

Conditions studied

  • Iron-deficiency
  • Vitamin A Deficiency
03

In context

Anemia, Iron-Deficiency

600 studies on the registry are indexed under Anemia, Iron-Deficiency; 95 are open to participants now.

This study's enrollment of 1,800 is above the median of 200 across 118 observational studies indexed under Anemia, Iron-Deficiency.

Browse Anemia, Iron-Deficiency studies →

Lead sponsor

Purdue University is the lead sponsor of 175 studies on the registry; 21 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Probability sample

Study population

This study will collect data about dietary habits for children and the household they lived. Adult caregivers will be approached and provided the relevant information.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adults (>18 years of age), with child(ren) 5 years of age living in the household.

Exclusion criteria

Exclusion Criteria:

  • No children under 5 y of age living in the household.
  • Not a caregiver for the children in the household.
05

Study design

Observational model
Cohort
Time perspective
Cross-sectional
Enrollment
1,800 participants (actual)
Patient registry
No

Interventions

  • OtherAcceptability of food-to-food fortified (FtFF) instant porridge flours

    This study will evaluate the market potential of a food-to-food fortified (FtFF) flour.

06

What researchers measure

Primary outcomes

  1. Assessment of staple intake in urban Senegalese households and children

    A quantitative, modified food frequency questionnaire (FFQ) will be used to assess consumption of various starch rich staples (rice, corn, sorghum, millet, potatoes, cassava) and starch-rich processed foods (bread) for the whole household and children. The caregiver will provide information about the child's amount and frequency of consumption. This will be measured in g/day\*child. The investigators will ask #times/week each staple was consumed as well as the average portion size consumed each time (g).

    Time frame: 10 weeks

  2. Assessment of the nutritional adequacy of urban Senegalese households and children

    Nutritional status of children in the household will be assessed using the Food Consumption Score Nutritional Quality Analysis (FCS-N) which was based on country-specific food groups. Food groups are orange fruits, orange vegetables, other fruits, eggs, dairy, organ meats, meat, fish, grains and legumes. Example of food items in the FCS-N assessment will be corroborated by a Senegalese maternal and child health expert. This will be measured in #times/week each food group was consumed.

    Time frame: 10 weeks

Secondary outcomes

  1. Nutritional impact of a fortified cereal-based product for the improvement of micronutrient deficiencies among children aged 24-60 months.

    Fortified flour consumption will be assessed by fortified flours intake (g/child\*day). Micronutrient contribution will calculated by multiplying the amount of flour consumed/child \* (mg zinc/g flour), (mg iron/g flour) and (ug RAE vitamin A/g flour).

    Time frame: 10 weeks

07

Study locations

1 site
  • ITA
    Dakar, Senegal
08

References and documents

Individual participant data

Plan to share: No — No PI was collected. There is not a plan to share participant information.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 1, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05872061
Lead sponsor
Purdue University
Responsible party
Bruce R. Hamaker (Principal Investigator / Distinguished professor, Purdue University) — Principal investigator
First posted
May 24, 2023
Start date
Jan 27, 2022
Primary completion
Apr 30, 2022
Completion
Apr 30, 2022
Last update
Jun 1, 2023

Study contacts

Bruce R Hamaker, PhD
principal investigator · Purdue University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion